Heron Therapeutics, Inc. (HRTX) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Heron Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.051 -- 00:00:03.312 Good day and thank you for standing by. Welcome to the Here on Therapeutics second quarter 00:00:03.312 -- 00:00:08.253 2026 earnings conference call. At this time, all participants are on a listen-only mode. 00:00:08.253 -- 00:00:11.254 After the speaker's presentation, there will be a question and answer session. 00:00:11.254 -- 00:00:14.814 To ask a question during the session, you need to press star 1-1 on your telephone. 00:00:14.814 -- 00:00:17.675 You will then hear an automated message advising your hand is raised. 00:00:17.675 -- 00:00:20.496 To withdraw your question, please press star 1-1 again. 00:00:20.496 -- 00:00:23.196 Please be advised today's conference is being recorded. 00:00:23.196 -- 00:00:25.237 I would now like to turn the conference over to your speaker today. 00:00:25.237 -- 00:00:28.197 Melissa Jarel, please go ahead. 00:00:29.933 -- 00:00:32.774 Thank you, operator, and good morning, everyone. 00:00:32.774 -- 00:00:36.876 Thank you for joining us on the Heron Therapeutics conference call today to discuss the 00:00:36.876 -- 00:00:40.838 company's financial results for the second quarter of 2026. 00:00:40.838 -- 00:00:46.120 With me today from Heron are Craig Collard, Chief Executive Officer, Ira Duarte, Executive 00:00:46.120 -- 00:00:50.702 Vice President, Chief Financial Officer, Bill Forbes, Executive Vice President, Chief 00:00:50.702 -- 00:00:56.004 Development Officer, Mark Hensley, Chief Operating Officer, and Kevin Warner, Senior 00:00:56.004 -- 00:00:59.198 Vice President, Medical Affairs, Strategy and Engagement. 00:00:59.198 -- 00:01:03.822 For those of you participating via conference call, slides are made available via webcast 00:01:03.822 -- 00:01:07.805 and can also be accessed via the inv...